Mutations in IDH genes, notably IDH1 and IDH2, have been extensively investigated in various cancers such as colon cancer (24), and these mutations may lead to alterations in cellular metabolism and epigenetic regulation, thereby contributing to tumorigenesis. This evidence concerns the gene IDH1 and colonic neoplasm.